IMUX vs. ALT
IMUX (Immunic, Inc.) and ALT (Altimmune, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, IMUX returned -41.49%/yr vs -28.25%/yr for ALT. At a 0.21 correlation, their price movements are largely independent.
Performance
IMUX vs. ALT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMUX achieves a 165.50% return, which is significantly higher than ALT's -20.50% return. Over the past 10 years, IMUX has underperformed ALT with an annualized return of -41.49%, while ALT has yielded a comparatively higher -28.25% annualized return.
IMUX
- 1D
- -3.21%
- 1M
- 33.43%
- YTD
- 165.50%
- 6M
- 118.00%
- 1Y
- 94.00%
- 3Y*
- -3.56%
- 5Y*
- -36.52%
- 10Y*
- -41.49%
ALT
- 1D
- -1.03%
- 1M
- -4.97%
- YTD
- -20.50%
- 6M
- -43.84%
- 1Y
- -47.05%
- 3Y*
- -12.34%
- 5Y*
- -26.02%
- 10Y*
- -28.25%
IMUX vs. ALT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IMUX Immunic, Inc. | 165.50% | -46.63% | -33.33% | 7.14% | -85.37% | -37.41% | 57.63% | 30.17% | -96.87% | 36.78% |
ALT Altimmune, Inc. | -20.50% | -49.93% | -35.91% | -31.61% | 79.59% | -18.79% | 496.83% | -8.25% | -96.55% | -47.79% |
Correlation
The correlation between IMUX and ALT is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Apr 21, 2014 | 0.21 |
The correlation between IMUX and ALT shifts across timeframes, from 0.21 (all time) to 0.32 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
IMUX:
$427.03M
ALT:
$357.21M
IMUX:
-$5.33
ALT:
-$0.92
IMUX:
2.82
ALT:
1.26
IMUX:
$0.00
ALT:
$36.00K
IMUX:
-$42.00K
ALT:
-$14.92M
IMUX:
-$105.11M
ALT:
-$93.48M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMUX vs. ALT — Risk / Return Rank
IMUX
ALT
IMUX vs. ALT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Immunic, Inc. (IMUX) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IMUX | ALT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.68 | ||
| Sortino ratioReturn per unit of downside risk | +2.15 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 0.97 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 1.74 | -0.71 | +2.45 |
| Martin ratioReturn relative to average drawdown | 3.43 | -0.98 | +4.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IMUX | ALT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.17 | -0.52 | +1.68 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.37 | -0.28 | -0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.35 | -0.19 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.33 | -0.17 | -0.17 |
Drawdowns
IMUX vs. ALT - Drawdown Comparison
The maximum IMUX drawdown since its inception was -99.96%, roughly equal to the maximum ALT drawdown of -99.63%. Use the drawdown chart below to compare losses from any high point for IMUX and ALT.
Loading charts...
Drawdown Indicators
| IMUX | ALT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -99.63% | -0.33% |
Max Drawdown (1Y)Largest decline over 1 year | -54.45% | -66.28% | +11.83% |
Max Drawdown (3Y)Largest decline over 3 years | -82.22% | -81.17% | -1.05% |
Max Drawdown (5Y)Largest decline over 5 years | -96.55% | -90.45% | -6.10% |
Max Drawdown (10Y)Largest decline over 10 years | -99.86% | -99.63% | -0.23% |
Current DrawdownCurrent decline from peak | -99.89% | -99.30% | -0.59% |
Average DrawdownAverage peak-to-trough decline | -87.37% | -78.88% | -8.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.50% | 48.04% | -20.54% |
Volatility
IMUX vs. ALT - Volatility Comparison
Immunic, Inc. (IMUX) has a higher volatility of 19.64% compared to Altimmune, Inc. (ALT) at 13.55%. This indicates that IMUX's price experiences larger fluctuations and is considered to be riskier than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMUX | ALT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.64% | 13.55% | +6.09% |
Volatility (6M)Calculated over the trailing 6-month period | 64.47% | 60.73% | +3.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.97% | 91.59% | -10.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.02% | 94.47% | +3.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 117.58% | 149.65% | -32.07% |
Dividends
IMUX vs. ALT - Dividend Comparison
Neither IMUX nor ALT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ALT Altimmune, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,462.31% |
IMUX Immunic, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
IMUX vs. ALT - Financials Comparison
This section allows you to compare key financial metrics between Immunic, Inc. and Altimmune, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IMUX and ALT have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMUX has higher volatility (19.64%) compared to ALT (13.55%). In terms of maximum drawdown, IMUX dropped -99.96% vs ALT's -99.63%.
IMUX currently has the higher Sharpe Ratio (1.17 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMUX and ALT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer